What Does LH Look Like at Each Phase of Your Cycle?

What Does LH Look Like at Each Phase of Your Cycle?

For most cycling women, LH stays low (1–12 IU/L) during the follicular and luteal phases, surges sharply to 25–100 IU/L at mid-cycle to trigger ovulation, then falls back within 24–48 hours. The main caveat: baseline LH that reads "normal" on a standard panel can still be abnormally timed or proportioned relative to FSH — that ratio matters as much as the raw number. Women with PCOS often show a chronically elevated tonic LH that makes the mid-cycle surge pattern nearly unreadable.

---

What LH Actually Is and Why It Spikes Only Once a Month

Luteinizing hormone is a glycoprotein produced by gonadotroph cells in the anterior pituitary gland. Its synthesis is driven by pulses of gonadotropin-releasing hormone (GnRH) from the hypothalamus, and its release is modulated by estrogen feedback — negative during most of the cycle, then strikingly positive just before ovulation (Hall 2019; doi.org/10.1210/er.2018-00151).

Unlike cortisol or thyroid hormone, LH doesn't maintain a steady baseline. It's secreted in pulses roughly every 60–90 minutes, with amplitude and frequency changing across cycle phases. This pulsatile pattern is why a single blood draw can mislead: two samples taken two hours apart on the same day can differ by 30–50%.

Standard reference ranges used by most labs:

Sources: Mayo Clinic Laboratories reference intervals; Gronowski & Schindler 2004; PMID: 15128046

These ranges are broad by design — they accommodate natural variation across body size, age, and assay methodology. What matters clinically is the pattern, not one data point.

---

LH Phase by Phase: What the Curve Should Look Like

Menstrual Phase (Days 1–5)

As progesterone falls at the end of the previous luteal phase, the corpus luteum degrades, the uterine lining sheds, and LH returns to its baseline trough — typically 2–7 IU/L. FSH rises slightly here to begin recruiting a new follicle cohort. The LH:FSH ratio at this point should be close to 1:1. A ratio persistently above 2:1 in early follicular blood work is one clinical indicator of PCOS (Balen et al., Human Reproduction Update 2016; PMID: 26508803).

Follicular Phase (Days 6–12)

As the dominant follicle grows and estradiol rises, LH pulses increase in frequency. This is the quiet build-up phase — LH typically stays between 3–12 IU/L. Crucially, rising estradiol initially suppresses LH via negative feedback at the pituitary. The follicle is essentially buying time to mature. If LH spikes too early in this phase, premature luteinization can occur, reducing egg quality.

The Ovulatory Surge (Days 13–15 in a 28-day cycle)

When estradiol crosses approximately 200 pg/mL and remains elevated for at least 36–48 hours, the feedback system flips from negative to positive (the "estrogen-positive feedback switch"). The hypothalamus releases a massive GnRH bolus, which drives LH to surge — often 8–10× baseline within 24 hours. This surge triggers the final maturation of the dominant follicle and the release of the egg approximately 36 hours after LH peak (Hoff et al., Journal of Clinical Endocrinology & Metabolism 1983; PMID: 6408578).

Urinary LH tests (OPKs) detect this surge 12–24 hours before peak serum LH. A serum sample catching the surge mid-climb will read very differently from one drawn at the apex.

Luteal Phase (Days 16–28)

After ovulation, LH drops sharply and remains low — typically 1–5 IU/L — while the corpus luteum produces progesterone under what little LH remains. This low-LH, high-progesterone environment is essential for implantation. If LH stays too high during the luteal phase (a pattern sometimes called "luteal LH hypersecretion"), early pregnancy loss risk may increase, though evidence remains debated (Regan et al., The Lancet 1990; PMID: 1969567).

---

How Stress Disrupts the LH Curve — and What You Can Actually Do About It

If you've noticed your cycle getting shorter, longer, or just unpredictable during high-stress periods, LH dysregulation is likely part of the mechanism. Cortisol and CRH (corticotropin-releasing hormone) directly suppress GnRH pulsatility at the hypothalamus. Fewer or weaker GnRH pulses mean a blunted LH surge — sometimes too small to trigger ovulation at all, producing an anovulatory cycle that still has withdrawal bleeding.

This is a stress-hormones-meet-reproductive-hormones story that plays out more commonly than most people realize. Chronic psychological stress, under-eating, overtraining, and poor sleep all converge on the hypothalamic-pituitary axis in ways that flatten the LH mid-cycle peak (Loucks et al., Journal of Clinical Endocrinology & Metabolism 1998; PMID: 9626137).

Practical strategies that have real evidence behind them:

1. Prioritize sleep consistency over duration. GnRH pulses are partly entrained by circadian rhythm. Irregular sleep timing disrupts the amplitude of early-morning LH pulses. Aim for a consistent wake time even on weekends.
2. Avoid extreme caloric restriction during the follicular phase. Energy availability below roughly 30 kcal/kg of lean mass per day reliably suppresses LH pulsatility in athletic women (Loucks et al. 1998).
3. Address the HPA axis directly. Adaptogens like Rhodiola rosea have demonstrated reductions in cortisol AUC in controlled trials (Olsson et al., Planta Medica 2009; PMID: 19016404), and a lower cortisol burden gives GnRH pulses more room to operate normally.
4. Track over multiple cycles, not one. A single anovulatory cycle under stress is not a disorder. Two or more consecutive anovulatory cycles warrant a workup.

For anyone connecting stress management to cycle health, the broader picture of what causes insomnia during a heavy period and insomnia in perimenopause with hypothyroidism illustrates how tightly interwoven hormonal and sleep disruptions really are — LH doesn't operate in isolation.

---

Why "Normal" LH on a Basic Lab Panel Can Still Be the Problem

Here's the frustration that doesn't get enough airtime: most primary care providers order LH as a single fasting morning draw, usually on an arbitrary day of the cycle. That number gets reported as "normal" if it falls within the wide follicular-phase reference range — even if the sample was taken on day 20 of a 28-day cycle, when LH should be at its luteal nadir.

A luteal-phase LH of 9 IU/L reported as "normal" is actually elevated for that phase. An ovulatory LH of 14 IU/L reported as "normal" may reflect a surge that never reached the threshold needed to release the egg.

This is why cycle-day-specific interpretation is non-negotiable. When you see your results, context is everything:

• Day 3 LH should be low (2–7). High early-follicular LH → PCOS screen.
• Day 12–14 LH should be surging. No surge detectable → consider anovulation.
• Day 21 LH should be low. Elevated here → luteal phase defect workup.

If your thyroid antibodies are elevated, that's another layer worth investigating — what causes thyroid antibodies to be out of range explains the downstream effects on ovulation and LH timing that are often missed.

---

The Mid-Cycle LH Surge and Sleep: A Relationship Most People Ignore

Sleep quality is rarely mentioned in discussions about LH, but the data are fairly clear: LH pulsatility is highest during the first few hours of sleep, and disrupted sleep architecture — particularly reduced slow-wave sleep — attenuates those pulses. In perimenopausal women, elevated tonic LH itself contributes to hot flashes and fragmented sleep, creating a feedback loop where poor sleep worsens LH dysregulation (Freedman 2014; PMID: 24259266).

The practical takeaway: if you're tracking LH to time ovulation and getting inconsistent results, your sleep schedule is a legitimate variable to examine alongside diet and training load.

For postpartum women, where LH suppression during breastfeeding is a distinct mechanism, what causes insomnia in the postpartum period covers how prolactin-mediated LH suppression intersects with the sleep disruptions new mothers experience.

---

Making Sense of LH in a Practical Context: Tracking Without Overthinking

You don't need to move into a lab to track LH meaningfully. Here's a streamlined approach:

Minimum useful protocol:

1. Day 3 serum LH + FSH (baseline ratio check)
2. Daily urine OPK strips from day 9 until surge detected
3. Day 21 serum progesterone (confirms ovulation occurred)
4. Optional: day 21 serum LH (should be low; >10 IU/L warrants follow-up)

What to do with the data:

• No detectable OPK surge in two consecutive cycles → consult your OB-GYN or reproductive endocrinologist
• LH:FSH ratio >2:1 on day 3 → discuss PCOS screening
• Surge detected but day 21 progesterone <10 ng/mL → possible luteal phase defect

Tracking LH also pairs well with understanding other cycle-phase markers. If you're also dealing with bloating during your period or itchy or dry skin during your cycle, those symptoms often share the same estrogen-progesterone imbalance that shows up in abnormal LH patterns — tracking one helps you understand the others.

---

What This Means for Your Formula

LH itself isn't a direct supplement target — you can't supplement LH. But the hormonal environment that governs LH pulsatility is absolutely addressable through well-dosed nutrition and adaptogens.

Rhodiola Rosea — Ones includes Rhodiola in formulas where HPA axis dysregulation is flagged through cortisol-related markers or stress history. At doses used in published trials (200–400mg of a standardized 3% rosavins extract), Rhodiola has been shown to reduce cortisol response to acute stress and improve subjective stress scores within 4 weeks (Olsson et al. 2009; PMID: 19016404). Lower baseline cortisol means less GnRH suppression, which supports a more robust LH surge.

Vitex Agnus-Castus (Chaste Tree Berry) — While not always discussed in mainstream supplement stacks, Vitex has documented dopaminergic activity at the pituitary that modulates prolactin and indirectly supports LH secretion patterns, particularly in luteal phase defect presentations (Schellenberg 2001; PMID: 11679022). Ones includes this in cycle-support formulas where luteal phase insufficiency or elevated prolactin is part of the clinical picture.

Vitamin D3 + K2 (MK-7) — Vitamin D receptors are expressed in the pituitary and ovary, and deficiency has been associated with irregular LH:FSH ratios and reduced ovarian reserve markers in observational studies. Ones formulas include D3 paired with MK-7 in clinically meaningful doses to support overall endocrine signaling — particularly relevant for women whose blood work shows 25-OH vitamin D below 40 ng/mL alongside cycle irregularity.

The Ones AI evaluates the full hormonal picture — not just LH in isolation — and builds a daily capsule formula calibrated to what your actual data shows.

---

Key Takeaways

• LH follows a predictable four-phase curve: low in early follicular, rising in late follicular, surging sharply at ovulation (25–100 IU/L), then falling to a luteal nadir of 1–5 IU/L.
• A single LH lab result is nearly meaningless without knowing the day of the cycle it was drawn — always interpret LH in cycle-day context.
• The LH:FSH ratio on day 3 (should be ≤1:1) is often more informative than either number alone; a ratio >2:1 warrants PCOS screening.
• Chronic stress suppresses GnRH pulsatility via cortisol and CRH, blunting the mid-cycle LH surge and increasing the risk of anovulatory cycles.
• Sleep disruption — especially irregular timing and reduced slow-wave sleep — attenuates LH pulse amplitude and can make ovulation tracking results unreliable.
• Adaptogens like Rhodiola that lower cortisol burden, and nutrients like Vitamin D3 that support pituitary receptor signaling, address the hormonal environment in which LH operates — this is where supplementation can make a meaningful difference.